BZD9L1 sirtuin inhibitor as a potential adjuvant for sensitization of colorectal cancer cells to 5-fluorouracil.
Yi Jer TanYeuan Ting LeeSven H PetersenGurjeet KaurKoji KonoSoo Choon TanAmin Malik Shah Abdul MajidChern-Ein OonPublished in: Therapeutic advances in medical oncology (2019)
This study may pave the way for use of BZD9L1 as an adjuvant to 5-FU in improving the therapeutic efficacy for the treatment of colorectal cancer.
Keyphrases